Logo image of VXX

IPATH SERIES B S&P 500 VIX (VXX) Stock Overview

USA - NYSEARCA:VXX - US06748M1962 - ETF

33.68 USD
0 (0%)
Last: 9/12/2025, 8:24:48 PM
33.74 USD
+0.06 (+0.18%)
After Hours: 9/12/2025, 8:24:48 PM
Fundamental Rating

2

Taking everything into account, VXX scores 2 out of 10 in our fundamental rating. VXX was compared to 391 industry peers in the Banks industry. VXX may be in some trouble as it scores bad on both profitability and health. VXX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year VXX was profitable.
VXX had a negative operating cash flow in the past year.
Each year in the past 5 years VXX has been profitable.
Of the past 5 years VXX 4 years had a positive operating cash flow.
VXX Yearly Net Income VS EBIT VS OCF VS FCFVXX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B

1.2 Ratios

Looking at the Return On Assets, with a value of 0.33%, VXX is doing worse than 82.10% of the companies in the same industry.
VXX has a worse Return On Equity (7.00%) than 62.92% of its industry peers.
Industry RankSector Rank
ROA 0.33%
ROE 7%
ROIC N/A
ROA(3y)0.32%
ROA(5y)0.31%
ROE(3y)6.92%
ROE(5y)6.46%
ROIC(3y)N/A
ROIC(5y)N/A
VXX Yearly ROA, ROE, ROICVXX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 6 8

1.3 Margins

With a Profit Margin value of 17.31%, VXX is not doing good in the industry: 69.82% of the companies in the same industry are doing better.
VXX's Profit Margin has improved in the last couple of years.
VXX does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 17.31%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-12.74%
PM growth 5Y11.07%
GM growth 3YN/A
GM growth 5YN/A
VXX Yearly Profit, Operating, Gross MarginsVXX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1

2. Health

2.1 Basic Checks

VXX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, VXX has less shares outstanding
Compared to 5 years ago, VXX has less shares outstanding
VXX has about the same debt/assets ratio as last year.
VXX Yearly Shares OutstandingVXX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B
VXX Yearly Total Debt VS Total AssetsVXX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500B 1T 1.5T

2.2 Solvency

A Debt/Equity ratio of 3.86 is on the high side and indicates that VXX has dependencies on debt financing.
VXX has a worse Debt to Equity ratio (3.86) than 94.37% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.86
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC5.95%
VXX Yearly LT Debt VS Equity VS FCFVXX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
VXX Yearly Current Assets VS Current LiabilitesVXX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

4

3. Growth

3.1 Past

VXX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 42.12%, which is quite impressive.
Measured over the past years, VXX shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.00% on average per year.
The Revenue has been growing slightly by 5.48% in the past year.
Measured over the past years, VXX shows a small growth in Revenue. The Revenue has been growing by 5.03% on average per year.
EPS 1Y (TTM)42.12%
EPS 3Y0.56%
EPS 5Y11%
EPS Q2Q%51.32%
Revenue 1Y (TTM)5.48%
Revenue growth 3Y7.87%
Revenue growth 5Y5.03%
Sales Q2Q%-52.04%

3.2 Future

The Earnings Per Share is expected to grow by 7.97% on average over the next years.
The Revenue is expected to grow by 3.56% on average over the next years.
EPS Next Y8.58%
EPS Next 2Y15.2%
EPS Next 3Y14.7%
EPS Next 5Y7.97%
Revenue Next Year8.41%
Revenue Next 2Y6.45%
Revenue Next 3Y5.44%
Revenue Next 5Y3.56%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
VXX Yearly Revenue VS EstimatesVXX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B
VXX Yearly EPS VS EstimatesVXX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

3

4. Valuation

4.1 Price/Earnings Ratio

VXX is valuated correctly with a Price/Earnings ratio of 13.05.
VXX's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 27.30. VXX is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 11.47 indicates a reasonable valuation of VXX.
VXX's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.73, VXX is valued a bit cheaper.
Industry RankSector Rank
PE 13.05
Fwd PE 11.47
VXX Price Earnings VS Forward Price EarningsVXX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VXX Per share dataVXX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

VXX's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as VXX's earnings are expected to grow with 14.70% in the coming years.
PEG (NY)1.52
PEG (5Y)1.19
EPS Next 2Y15.2%
EPS Next 3Y14.7%

3

5. Dividend

5.1 Amount

VXX has a Yearly Dividend Yield of 2.30%. Purely for dividend investing, there may be better candidates out there.
In the last 3 months the price of VXX has falen by -38.93%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
VXX's Dividend Yield is slightly below the industry average, which is at 3.56.
Compared to an average S&P500 Dividend Yield of 2.45, VXX has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.3%

5.2 History

On average, the dividend of VXX grows each year by 6.61%, which is quite nice.
VXX is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)6.61%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

VXX's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DPN/A
EPS Next 2Y15.2%
EPS Next 3Y14.7%
VXX Yearly Income VS Free CF VS DividendVXX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B

IPATH SERIES B S&P 500 VIX

NYSEARCA:VXX (9/12/2025, 8:24:48 PM)

After market: 33.74 +0.06 (+0.18%)

33.68

0 (0%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)07-29 2025-07-29/bmo
Earnings (Next)10-22 2025-10-22
Inst Owners51.51%
Inst Owner Change-6.63%
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap118.27B
Analysts79.09
Price Target42.93 (27.46%)
Short Float %0.25%
Short Ratio1.59
Dividend
Industry RankSector Rank
Dividend Yield 2.3%
Yearly Dividend0.87
Dividend Growth(5Y)6.61%
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.23%
Min EPS beat(2)13.75%
Max EPS beat(2)16.7%
EPS beat(4)4
Avg EPS beat(4)29.84%
Min EPS beat(4)13.75%
Max EPS beat(4)64.16%
EPS beat(8)8
Avg EPS beat(8)28.97%
EPS beat(12)12
Avg EPS beat(12)22.72%
EPS beat(16)16
Avg EPS beat(16)27.45%
Revenue beat(2)2
Avg Revenue beat(2)2.74%
Min Revenue beat(2)1.38%
Max Revenue beat(2)4.11%
Revenue beat(4)4
Avg Revenue beat(4)2.75%
Min Revenue beat(4)1.38%
Max Revenue beat(4)4.11%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-12.15%
PT rev (3m)-30.43%
EPS NQ rev (1m)-3.14%
EPS NQ rev (3m)-9.21%
EPS NY rev (1m)-1.59%
EPS NY rev (3m)-0.93%
Revenue NQ rev (1m)-1.93%
Revenue NQ rev (3m)-1.46%
Revenue NY rev (1m)0.75%
Revenue NY rev (3m)0.93%
Valuation
Industry RankSector Rank
PE 13.05
Fwd PE 11.47
P/S 2.85
P/FCF N/A
P/OCF N/A
P/B 1.15
P/tB 1.29
EV/EBITDA N/A
EPS(TTM)2.58
EY7.66%
EPS(NY)2.94
Fwd EY8.72%
FCF(TTM)-3.91
FCFYN/A
OCF(TTM)-3.91
OCFYN/A
SpS11.81
BVpS29.21
TBVpS26.06
PEG (NY)1.52
PEG (5Y)1.19
Profitability
Industry RankSector Rank
ROA 0.33%
ROE 7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 17.31%
GM N/A
FCFM N/A
ROA(3y)0.32%
ROA(5y)0.31%
ROE(3y)6.92%
ROE(5y)6.46%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-12.74%
PM growth 5Y11.07%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 3.86
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC5.95%
ROIC/WACCN/A
Cap/Depr(3y)89.52%
Cap/Depr(5y)85.55%
Cap/Sales(3y)5.72%
Cap/Sales(5y)5.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)42.12%
EPS 3Y0.56%
EPS 5Y11%
EPS Q2Q%51.32%
EPS Next Y8.58%
EPS Next 2Y15.2%
EPS Next 3Y14.7%
EPS Next 5Y7.97%
Revenue 1Y (TTM)5.48%
Revenue growth 3Y7.87%
Revenue growth 5Y5.03%
Sales Q2Q%-52.04%
Revenue Next Year8.41%
Revenue Next 2Y6.45%
Revenue Next 3Y5.44%
Revenue Next 5Y3.56%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-25.18%
FCF growth 3Y-51.04%
FCF growth 5YN/A
OCF growth 1Y-25.18%
OCF growth 3Y-47.42%
OCF growth 5YN/A